Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions
This study has been completed.
Study NCT00779376   Information provided by Ranbaxy Inc.

First Received on October 23, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial